Melian Agustin
- SEC CIK
- 0001818064
No open-market purchases or sales filed in the past year.
Current role at each company
- FMTX Forma Therapeutics Holdings, Inc.EVP, Research & Developmentas of Oct 14, 2022
- KLRS Kalaris Therapeutics, Inc.Chief Medical Officeras of Oct 5, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Melian Agustin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KLRS Kalaris Therapeutics, Inc.
Chief Medical Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 (view filing) | Oct 4 | 1 day | Melian AgustinChief Medical Officer | SSale | −18.7K | $23.91 | −$446.9K | −4.0%453.5K after | 4 lots |
| Sep 29, 2021 (view filing) | Sep 28 | 1 day | Melian AgustinChief Medical Officer | SSale | −3.75K | $24.12 | −$90.5K | −0.8%472.2K after | |
| Sep 20, 2021 (view filing) | Apr 5-Sep 17 | 168 daysLate | Melian AgustinChief Medical Officer | SSale | −40.5K | $22.11 | −$896.7K | −7.9%476.0K after | 4 lots |